0000899243-16-012927.txt : 20160209 0000899243-16-012927.hdr.sgml : 20160209 20160209175422 ACCESSION NUMBER: 0000899243-16-012927 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160205 FILED AS OF DATE: 20160209 DATE AS OF CHANGE: 20160209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCKEON BRIAN P CENTRAL INDEX KEY: 0001219445 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 161401349 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-05 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001219445 MCKEON BRIAN P ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 EVP, CFO and Treasurer Common Stock 2016-02-05 4 M 0 1880 53.185 A 32461 D Common Stock 2016-02-08 4 M 0 9054 17.185 A 41515 D Common Stock 2016-02-08 4 S 0 4200 69.1683 D 37315 D Common Stock 2016-02-08 4 S 0 4854 70.0619 D 32461 D Incentive Stock Option (right-to-buy) 53.185 2016-02-05 4 M 0 1880 D 2023-12-31 Common Stock 1880 5640 D Non-Qualified Stock Option (right-to-buy) 17.185 2016-02-08 4 M 0 9054 D 2016-02-13 Common Stock 9054 0 D The number of securities reported reflects a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015 (the "Stock Split"). Sale made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Represents the weighted average sales price of the shares sold ranging from a low of $68.73 to a high of $69.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $69.76 to a high of $70.33 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This option vests in five equal annual installments, beginning on the first anniversary date (01/01/2015) of the date of grant. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,527 shares on February 14, 2010, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon 2016-02-09